“…Ingenol mebutate (picato; Figure 1) was recently approved by the FDA as a first‐in‐class drug for the topical treatment of actinic keratosis, a precancerous skin condition 6. Consequently, some elegant synthetic strategies for the formation of bridged seven‐membered‐ring systems have been developed,1g,h, 2e including rearrangement,1d,f, 4f fragmentation,1c, 4e ring‐closing metathesis,1e and intramolecular cyclizations 2c,d. 3c However, so far no general reactions are available for the direct and efficient synthesis of bridged cycloheptane bicyclic systems.…”